Wednesday 27 June 2018

Reuters Health Report: AstraZeneca, Merck eye $1 billion boost from cancer drug success

AstraZeneca, Merck eye $1 billion boost from cancer drug success

LONDON (Reuters) - AstraZeneca's oncology business received a boost on Wednesday as results of a clinical trial showed its drug Lynparza helped women with ovarian cancer live longer without their disease worsening when given as a first-line treatment.

U.S. top court blocks California law on anti-abortion centers

WASHINGTON (Reuters) - The U.S. Supreme Court on Tuesday blocked a California law requiring clinics that counsel women against abortion to notify clients of the availability of abortions paid for by the state, finding that it violated the free speech rights of these Christian-based facilities.

Abortion safety similar at surgery centers and doctors' offices

(Reuters Health) - - Women who get abortions at clinics or doctors' offices may be no more likely to experience serious complications than patients who have these procedures at surgery centers, a U.S. study suggests.

Exclusive: BrainStorm will not provide ALS therapy under U.S. Right to Try act

TEL AVIV (Reuters) - BrainStorm Cell Therapeutics Inc will not make its experimental stem cell treatment for neurodegenerative diseases available under the new U.S. "Right to Try" (RTT) act, citing a failure to find a way to enable all patients to afford the treatment.

U.S. approves first marijuana plant-derived drug for epilepsy

(Reuters) - The U.S. health regulator approved GW Pharmaceuticals Plc's epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis.

FDA knocks back Achaogen's drug for bloodstream infection

(Reuters) - The U.S. Food and Drug Administration cleared Achaogen Inc's antibiotic to treat adults with complicated urinary tract infections, but shares slumped 25 percent as the drug failed to win approval for treating bloodstream infections.

Pride and worry, Britain's free health service turns 70

MILTON KEYNES, England (Reuters) - Free, good quality healthcare for everyone, from cradle to grave. That was the mission of Britain's National Health Service when it was founded on July 5, 1948.

Older women still need bone checks to prevent fractures

(Reuters Health) - Women 65 and older should keep getting screened for osteoporosis, or porous, fragile bones that are prone to fractures, U.S. doctors recommend.

Long-term fiber intake may help preserve bowel control

(Reuters Health) - Women who include a lot of fiber in their diets may have a lower risk for problems with bowel control as they age, a study suggests.

China reports highly pathogenic H5N1 bird flu at chicken farm: OIE

BEIJING/PARIS (Reuters) - China reported an outbreak of highly pathogenic H5N1 bird flu at a farm in its northwest Qinghai province, the Paris-based World Organisation for Animal Health (OIE) said on Tuesday, citing a report from the Chinese agriculture ministry.

Related Videos

High pot taxes are a drag for Californians

Treadmill tests show polar bears to be efficient walkers

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here